Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Am J Physiol Renal Physiol ; 321(1): F33-F46, 2021 07 01.
Article in English | MEDLINE | ID: mdl-34029144

ABSTRACT

Papillary renal cell carcinoma (pRCC) represents the second most common kidney cancer and can be distinguished from other types based on its unique histological architecture and specific pattern of genomic alterations. Sporadic type 1 pRCC is almost universally driven by focal or chromosomal amplification of the receptor tyrosine kinase MET, although the specific mode of its activation is unclear. Although the MET receptors found in human tumor specimens appear highly active, those found on the surface of in vitro-cultured tumor cells are only weakly activated in the absence of exogenous hepatocyte growth factor ligand. Furthermore, pRCC cells cultured in standard two-dimensional conditions with serum fail to respond functionally to MET knockdown or the selective MET inhibitor capmatinib despite clear evidence of kinase inhibition at the molecular level. To better model pRCC in vitro, we developed a three-dimensional coculture system in which renal tumor cells are layered on top of primary fibroblasts in a fashion that mimics the papillary architecture of human tumors. In this three-dimensional spheroid model, the tumor cells survive and proliferate in the absence of serum due to trophic support of hepatocyte growth factor-producing fibroblasts. Unlike tumor cells grown in monoculture, the proliferation of cocultured tumor cells is sensitive to capmatinib and parallels inhibition of MET kinase activity. These findings demonstrate the importance of stromal fibroblasts in pRCC and indicate that accurate in vitro representation of this disease requires the presence of both tumor and fibroblast cells in a structured coculture model.NEW & NOTEWORTHY Two-dimensional monoculture of papillary renal cancer cells fails to replicate several features of the disease found in humans. We hypothesized that this discordance results from lack of trophic support from renal fibroblasts, which are involved in the architecture of human papillary renal tumors. We found that three-dimensional layering of renal cancer cells on top of a fibroblast core using magnetic bioprinting produces a structured spheroid that more faithfully mimics the behavior of human tumors.


Subject(s)
Carcinoma, Renal Cell/pathology , Coculture Techniques , Fibroblasts/metabolism , Kidney Neoplasms/pathology , Biomarkers, Tumor/genetics , Carcinoma, Renal Cell/genetics , Coculture Techniques/methods , Gene Expression/physiology , Humans , Kidney Neoplasms/metabolism , Protein Kinase Inhibitors/metabolism , Proto-Oncogene Proteins c-met/metabolism
2.
Sci Rep ; 8(1): 5996, 2018 04 16.
Article in English | MEDLINE | ID: mdl-29662228

ABSTRACT

Development of complex neural circuits like the peripheral somatosensory system requires intricate mechanisms to ensure axons make proper connections. While much is known about ligand-receptor pairs required for dorsal root ganglion (DRG) axon guidance, very little is known about the cytoplasmic effectors that mediate cellular responses triggered by these guidance cues. Here we show that members of the Cas family of cytoplasmic signaling adaptors are highly phosphorylated in central projections of the DRG as they enter the spinal cord. Furthermore, we provide genetic evidence that Cas proteins regulate fasciculation of DRG sensory projections. These data establish an evolutionarily conserved requirement for Cas adaptor proteins during peripheral nervous system axon pathfinding. They also provide insight into the interplay between axonal fasciculation and adhesion to the substrate.


Subject(s)
Axon Fasciculation , Crk-Associated Substrate Protein/metabolism , Ganglia, Spinal/growth & development , Animals , Crk-Associated Substrate Protein/analysis , Crk-Associated Substrate Protein/genetics , Ganglia, Spinal/metabolism , Ganglia, Spinal/ultrastructure , Gene Expression Regulation, Developmental , Mice , Phosphorylation , RNA, Messenger/analysis , RNA, Messenger/genetics , Spinal Cord/growth & development , Spinal Cord/metabolism , Spinal Cord/ultrastructure
3.
Biochimie ; 137: 99-105, 2017 Jun.
Article in English | MEDLINE | ID: mdl-28322926

ABSTRACT

Caffeine has been shown to be a robust uncompetitive inhibitor of glucose uptake in erythrocytes. It preferentially binds to the nucleotide-binding site on GLUT1 in its tetrameric form and mimics the inhibitory action of ATP. Here we demonstrate that caffeine is also a dose-dependent, uncompetitive inhibitor of 2-deoxyglucose (2DG) uptake in L929 fibroblasts. The inhibitory effect on 2DG uptake in these cells was reversible with a rapid onset and was additive to the competitive inhibitory effects of glucose itself, confirming that caffeine does not interfere with glucose binding. We also report for the first time that caffeine inhibition was additive to inhibition by curcumin, suggesting distinct binding sites for curcumin and caffeine. In contrast, caffeine inhibition was not additive to that of cytochalasin B, consistent with previous data that reported that these two inhibitors have overlapping binding sites. More importantly, we show that the magnitude of maximal caffeine inhibition in L929 cells is much lower than in erythrocytes (35% compared to 90%). Two epithelial cell lines, HCLE and HK2, have both higher concentrations of GLUT1 and increased basal 2DG uptake (3-4 fold) compared to L929 cells, and subsequently display greater maximal inhibition by caffeine (66-70%). Interestingly, activation of 2DG uptake (3-fold) in L929 cells by glucose deprivation shifted the responsiveness of these cells to caffeine inhibition (35%-70%) without a change in total GLUT1 concentration. These data indicate that the inhibition of caffeine is dependent on the activity state of GLUT1, not merely on the concentration.


Subject(s)
Caffeine/pharmacology , Deoxyglucose/metabolism , Epithelial Cells/drug effects , Erythrocytes/drug effects , Fibroblasts/drug effects , Glucose Transporter Type 1/antagonists & inhibitors , Biological Transport , Blotting, Western , Central Nervous System Stimulants/pharmacology , Cytochalasin B/pharmacology , Epithelial Cells/metabolism , Erythrocytes/metabolism , Fibroblasts/metabolism , Gene Expression Regulation/drug effects , Humans , Signal Transduction/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...